Pharma’s Coup Attempt: How Cartel Insiders Are Plotting to Oust Robert F. Kennedy, Jr.

A leaked memo from one of the pharma cartel’s most powerful trade groups has revealed a desperate plan to push Robert F. Kennedy, Jr. out of his role as United States Secretary of Health and Human Services (HHS). The document, apparently originating from a closed-door meeting of the Biotechnology Innovation Organization (BIO), shows that industry leaders are prepared to spend millions of dollars lobbying Congress and manipulating public opinion to force Kennedy from his job. At stake is not just U.S. government vaccine policy, but the deeper question of who actually runs public health in America – democratically elected officials, or the corporations that profit from disease.

The plan unveiled

The memo appears to come from BIO’s Vaccine Policy Steering Committee, a powerful body representing companies such as Pfizer, Merck, Novavax, and Vaxcyte. According to whistleblowers, the group met on April 3, 2025, to discuss the “threat” posed by Kennedy’s healthcare reform agenda. The summary leaves no doubt about its intentions. One line is especially blunt: “It is time to go to The Hill and lobby that it is time for RFK Jr. to go.”

The threat to the cartel is clear. Kennedy has insisted on long-term safety data for vaccines, full publication of trial results, and the restoration of manufacturer liability for injuries. These proposals would dramatically slow down the fast-track approvals and legal protections that have allowed vaccine makers to rake in billions while avoiding accountability. In the eyes of BIO, this is not just policy reform – it is a direct attack on its business model.

Fear of accountability

BIO’s real fear is not scientific debate but financial disruption. The memo quotes one executive from Vaxcyte warning that “investors have stated they are leaving until the next data read out,” citing uncertainty caused by Kennedy’s push for tighter regulation. Capital, in other words, is fleeing the vaccine sector. Instead of reassuring the public with stronger safety standards, BIO is working to reassure Wall Street by removing the man calling for reform.

This exposes the heart of the problem: the pharmaceutical industry has become so dependent on weak oversight and political protection that it views accountability itself as a threat. Rather than adapt to higher safety expectations, BIO would rather manipulate politics to preserve the old system.

Buying influence

The most revealing part of the plan is financial. BIO has committed $2 million to a new communications campaign titled ‘Why We Vaccinate.’ But this is no ordinary public health initiative. According to the memo, its goal is not education but “inspire and frighten” messaging designed to sway the “movable middle” of public opinion. Essentially, by tying vaccination to national security, economic productivity, and workforce resilience, the campaign seeks to use fear as a political weapon.

This is not science. It is psychology. Instead of engaging Kennedy’s arguments on their merits, BIO plans to drown out discussion with a flood of fear-based advertising and carefully managed surrogates. Among those mentioned as possible allies are Dr. Mehmet Oz and Senator Bill Cassidy. These figures are expected to provide a veneer of bipartisan legitimacy while avoiding any real debate about the substance of Kennedy’s proposals.

Controlling the narrative

Equally troubling is BIO’s strategy of redefining language itself. The leaked document reveals plans to replace words like “protect” and “defend” with softer-sounding terms such as “streamline,” “optimize,” and “enhance.” But behind the rebranding lies a cynical truth. As Robert W. Malone MD has pointed out, when BIO says “efficiency,” it means fewer safety checks. When it says “transparency,” it means PR-polished talking points, not the release of raw scientific data. When it says “resilience,” it means consumer obedience, not real safeguards.

This is not reform – it is narrative disingenuity that would not be out of place in George Orwell’s dystopian novel Nineteen Eighty-Four. BIO is attempting to control the vocabulary while ensuring that nothing actually changes. It is a form of deception that goes beyond lobbying, seeking to manipulate the very terms of debate so the public never realizes reform has been hollowed out.

The plot is already underway

The memo points to this month (September 2025) as a critical deadline. Congress is back in full session, budget negotiations are getting underway, and the media cycle is returning to full speed after the summer lull. BIO’s campaign is timed to seize this moment, flooding the airwaves with its ‘Why We Vaccinate’ messaging before Kennedy’s reform agenda gains traction.

September also marks the reopening of schools, a time when vaccine debates are most prominent in the public eye. By striking early, BIO hopes to dominate the narrative and silence Kennedy before he can rally broader public support. For the pharma industry, this is not about science but survival.

Significantly, therefore, in the past couple of days, we have already seen nine former leaders of the Centers for Disease Control and Prevention (CDC) speaking out against Kennedy, publishing an open letter in The New York Times that criticizes his policies.

Separately, and simultaneously, more than 1,000 current and former HHS employees are said to be calling for Kennedy to either resign or be fired. Their letter – which does not name the signatories but mentions vaccines eight times – accuses him of endangering the nation’s health. It is difficult not to see the hand of BIO behind these moves.

A threat to democracy

The implications of this plot go far beyond health policy. If corporations can secretly conspire to spend millions lobbying for the removal of a sitting government official, then democracy itself is in danger. Whether one agrees with Kennedy’s policies or not, it should not be the pharmaceutical lobby that decides who serves in public office. That decision belongs to the people and their elected representatives, not to an industry that stands to profit from the outcome.

This is why the BIO leak matters so much. It shines a light on the machinery of influence that usually operates in the shadows – closed-door meetings, carefully managed talking points, and money flowing into Washington to buy outcomes that serve shareholders instead of citizens.

Who decides about global health?

The BIO plot also has international implications, as it aligns with broader efforts to centralize health policy through global treaties and the algorithmic censorship of dissenting medical views. If left unchecked, this could lead to a future where drug companies, aided by international bodies, dictate not only U.S. policy but all global health decisions as well. The Kennedy reforms represent a direct challenge to that vision.

Ultimately, therefore, this story is not just about Robert F. Kennedy, Jr. It is about whether public health will be guided by the principles of science, safety, and consent – or by the profit motives of an industry that sees accountability as a threat. Seen in this light, BIO’s efforts to remove Kennedy are not a sign of power. They are an admittance of weakness.

Kennedy’s reforms may be inconvenient for Wall Street, but they reflect the public’s increasing demands for safety, consent, and honesty in medicine. The real question now is whether corporations will continue to dictate the rules – or whether the American people can successfully reclaim health policy for the public good.

• Bio
• Latest Posts

Paul Anthony Taylor

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU'”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings.

Prior to joining the Foundation, Paul's background was in the music industry, where he worked as a keyboard player and programmer with artists including Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas, and Primal Scream.

He first became interested in natural health after falling ill with a chronic fatigue syndrome-related disorder in 1991 and subsequently making a full recovery through the use of natural health therapies. After meeting Dr. Rath and Dr. Niedzwiecki at an anti-Codex rally in Berlin in 2002, Paul was inspired to make a life-changing decision to leave the music industry to work for the Foundation and help defend the right of patients worldwide to have free access to natural health approaches.

You can find Paul on Twitter at @paulanthtaylor

Der Executive Director der Dr. Rath Health Foundation ist einer der Koautoren des explosiven Buchs „Die Nazi-Wurzeln der Brüsseler EU“. Paul ist auch unser Experte zum Thema „Codex Alimentarius-Kommission“ und hat Augenzeugenerfahrung als offizieller beobachtender Teilnehmer bei diesen Treffen.

Bevor er seine Arbeit bei der Stiftung antrat war Paul in der Musikindustrie aktiv. Er arbeitete als Keyboard-Spieler und Programmierer mit Künstlern wie Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas und Primal Scream.

Sein Interesse an natürlicher Gesundheit wuchs, als er 1991 an Störungen erkrankte, die aus einem chronischen Erschöpfungssyndrom resultierten. Durch natürliche Gesundheitstherapien wurde er schließlich vollständig geheilt. Ein Treffen 2002 mit Dr. Rath und Dr. Niedzwiecki bei einer Anti-Codex-Demonstration in Berlin inspirierte ihn zu einer lebensverändernden Entscheidung und er verließ die Musikindustrie um für die Stiftung zu arbeiten und das Recht der Patienten zu verteidigen, weltweit freien Zugang zu natürlichen Gesundheitsverfahren zu haben.

Auf Twitter ist Paul unter @paulanthtaylor zu finden.

Latest posts by Paul Anthony Taylor (see all)

• Ebola Returns: Twelve Years After Dr. Rath’s Warning, Has the World Learned Nothing? - May 22, 2026
• Coenzyme Q10 and High Blood Pressure: The Overlooked Micronutrient That Doctors Can No Longer Ignore - May 15, 2026
• Growing Evidence of the Benefits of Vitamin D in Multiple Sclerosis - May 8, 2026
• Bilderberg 2026: When Power Meets in Secret, Democracy Pays the Price - April 24, 2026
• Europe’s ‘War on Vitamins’ Returns: How European Union Restrictions Risk Deepening a Silent Public Health Crisis - April 17, 2026